03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Jerry Greenfield
Professor, Garvan Institute of Medical Research
press citations on 1 topic since 24 Nov 2025 · last quoted 30 Nov 2025
02 Quoted on · 1 of 29 topics
Jerry Greenfield: key facts
- Kind of voice
- Academic
- Role
- Professor, Garvan Institute of Medical Research
- Quoted on
- Diabetes
- Tracked press citations
- 4
- Most recently quoted
- 30 Nov 2025
- First quoted
- 24 Nov 2025
04 The signal · where Jerry Greenfield sits on diabetes
Ranked 29= of 100 voices quoted in the press on diabetes, level with 18 others on 4 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK36 - 2
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20 - 3=
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15 - 29=Dr Robbie LyndsayAcademicNational Diabetes Lead, NHS Scotland4
- 29=Jennifer SnaithClinicianDr, co-leader of the study, Garvan Institute of Medical Research4
- 29=Jerry GreenfieldAcademicProfessor, Garvan Institute of Medical Research4
- 48=Dominic GreenyerClinicianGP and director of The Health Suite3
- 48=Henry GreggSector leaderChief Executive, National Pharmacy Association3
Showing the leaders and the ranks around 29=, of 100 voices · See every voice on the topic →
05 On the record · press
What Jerry Greenfield has said
- bristolpost.co.uk1
- getsurrey.co.uk1
- mirror.co.uk1
- technologynetworks.com1
Where Jerry Greenfield has been quoted
- 01New study says type 1 diabetes 'improved by cheap medicine' - The Mirrormirror.co.uk · 30 Nov 2025
- 02New study finds cheap century-old medication 'can improve type 1 diabetes' | Surrey Livegetsurrey.co.uk · 30 Nov 2025
- 03Metformin Behaves Differently in Type 1 Diabetestechnologynetworks.com · 27 Nov 2025
- 04New hope for people with diabetes after metformin research | Bristol Livebristolpost.co.uk · 24 Nov 2025
Verbatim
“Metformin has been available in various forms for around 100 years, but its mechanism of action remains unknown. We would have expected that the observed reductions in insulin dose induced by metformin in our study would be due to the body becoming more sensitive to insulin, that is, becoming less insulin resistant.”
“Metformin has been available in various forms for around 100 years, but its mechanism of action remains unknown. We would have expected that the observed reductions in insulin dose induced by metformin in our study would be due to the body becoming more sensitive to insulin, that is, becoming less insulin resistant.”
“Metformin has been available in various forms for around 100 years, but its mechanism of action remains unknown. We would have expected that the observed reductions in insulin dose induced by metformin in our study would be due to the body becoming more sensitive to insulin, that is, becoming less insulin resistant. But we have shown that is not the case.”
“Our priority is now working out how metformin is achieving this effect.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.